Class ITerminatedD-0323-2024
Drug recall · February 7, 2024
Zenzedi recall
Why: Labeling: Label Mix-up
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Georgia, 30328, NDC 24338-856-03
- Lots / codes
Lot # F230169A, Exp. 06/30/2025
- Quantity
- 4,662 bottles
- Company
- Azurity Pharmaceuticals, Inc., Wilmington, MA
- Distribution
- USA nationwide
- Initiated
- January 4, 2024 · Voluntary: Firm initiated
- Classified
- February 12, 2024
- Reported
- February 7, 2024
- Ended
- September 18, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Zenzedi
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.